HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Primary signet ring cell carcinoma of the urinary bladder successfully treated with intra-arterial chemotherapy alone.

Abstract
A 65-year-old man presented with the complaint of gross hematuria. Cystoscopy revealed a sessile tumor on the left bladder wall. It was diagnosed as primary signet ring cell carcinoma of the bladder (T3bN0M0). The patient did not want surgical treatment. Therefore, three courses of arterial infusion of carboplatin were administered at 3-week intervals. Complete remission was obtained and has been maintained for 44 months. Our case appears to be the first report of successful treatment with chemotherapy alone of an infiltrating signet ring cell carcinoma of the bladder.
AuthorsYasuhiro Hirano, Kazuo Suzuki, Kimio Fujita, Hiroshi Furuse, Ken Fukuta, Motoaki Kitagawa, Yoshio Aso
JournalUrology (Urology) Vol. 59 Issue 4 Pg. 601 (Apr 2002) ISSN: 1527-9995 [Electronic] United States
PMID11927332 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Carboplatin
Topics
  • Aged
  • Antineoplastic Agents (therapeutic use)
  • Carboplatin (therapeutic use)
  • Carcinoma, Signet Ring Cell (complications, drug therapy, pathology)
  • Hematuria (etiology)
  • Humans
  • Infusions, Intra-Arterial (methods)
  • Male
  • Urinary Bladder Neoplasms (complications, drug therapy, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: